SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-117952
Filing Date
2021-09-21
Accepted
2021-09-21 17:13:40
Documents
14
Period of Report
2021-09-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2128154d1_8k.htm   iXBRL 8-K 28678
2 EXHIBIT 99.1 tm2128154d1_ex99-1.htm EX-99.1 10622
6 GRAPHIC tm2128154d1_ex99-1img001.jpg GRAPHIC 5595
  Complete submission text file 0001104659-21-117952.txt   226855

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA syn-20210921.xsd EX-101.SCH 3215
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20210921_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20210921_pre.xml EX-101.PRE 22731
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2128154d1_8k_htm.xml XML 3619
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 211267183
SIC: 2834 Pharmaceutical Preparations